HaloVax
HaloVax is a special purpose subsidiary of Voltron Therapeutics which reached an agreement with Hoth Therapeutics to co-develop a SARS-CoV-2 vaccine using Voltron's self-assembling vaccine technology.
B2X
Business Model
Licensing
Company Operating Status
Active
Email Address
pgallagher@luciuspartnersllc.com
0
mduffy@luciuspartnersllc.com
0
Facebook URL
Instagram URL
Location
Parent Organization
Phone Number
+16463355923
0
+19732166014
0
Pitchbook URL
Twitter URL
Official Website
Find more companies like HaloVax
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
